IP Library Patent Application 16819896
Patent Application
App. No. 16/819,896

NUCLEIC ACID-GUIDED NUCLEASES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/819,896
Abstract

Disclosed herein are nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Disclosed herein are engineered non-naturally occurring nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Targetable nuclease systems can be used to edit genetic targets, including recursive genetic engineering and trackable genetic engineering methods.

Claims (28)

1 . A method of modifying a target region in the genome of a cell, the method comprising:

(a) contacting a cell with:

a non-naturally occurring nucleic acid-guided nuclease encoded by a nucleic acid having at least 90% identity to SEQ ID No. 22, SEQ ID No. 42, SEQ ID No. 128 or SEQ ID No. 148;

an engineered guide nucleic acid capable of complexing with the nucleic acid-guided nuclease; and

an editing sequence encoding a nucleic acid complementary to the target region having a change in sequence relative to the target region and a mutation in a protospacer adjacent motif (PAM) sequence; and

(b) allowing the nuclease, guide nucleic acid and editing sequence to create a genome edit in a target region of the genome of the cell.

2 . The method of claim 1 , wherein the engineered guide nucleic acid and the editing sequence are provided as a single nucleic acid.

3 . The method of claim 1 , wherein the engineered guide nucleic acid comprises SEQ ID No. 88, SEQ ID No. 93 or SEQ ID No. 94.

4 . The method of claim 1 , wherein the nucleic acid-guided has less than 40% protein identity to SEQ ID No. 12 and SEQ ID No. 108.

5 . The method of claim 1 , wherein the nucleic acid-guided nuclease is codon optimized for the cell to be edited.

6 . The method of claim 5 , wherein the nucleic acid-guided nuclease is codon optimized for E. coli.

7 . The method of claim 5 , wherein the nucleic acid-guided nuclease is codon optimized for S. cerevisiae.

8 . The method of claim 5 , wherein the nucleic acid-guided nuclease is codon optimized for mammalian cells.

9 . The method of claim 1 , wherein the non-naturally occurring nucleic acid-guided nuclease is encoded by a nucleic acid having at least 95% identity to SEQ ID No. 22, SEQ ID No. 42, SEQ ID No. 128 or SEQ ID No. 148.

10 . The method of claim 1 , wherein the non-naturally occurring nucleic acid-guided nuclease is encoded by a nucleic acid having greater than 95% identity to SEQ ID No. 22, SEQ ID No. 42, SEQ ID No. 128 or SEQ ID No. 148.

11 . A nucleic acid-guided nuclease system comprising:

(a) a non-naturally occurring nuclease encoded by a nucleic acid having at least 90% identity to SEQ ID No. 22, SEQ ID No. 42, SEQ ID No. 128 or SEQ ID No. 148;

(b) an engineered guide nucleic acid capable of complexing with the nucleic acid-guided nuclease, and

(c) an editing sequence having a change in sequence relative to the sequence of a target region in a genome of a cell and a mutation in a protospacer adjacent motif (PAM) sequence; wherein the system results in a genome edit in the target region of the genome of the cells facilitated by the nuclease, the engineered guide nucleic acid and the editing sequence.

12 . The system of claim 11 , wherein the engineered guide nucleic acid comprises SEQ ID No. 88, SEQ ID No. 93 or SEQ ID No. 94.

13 . The system of claim 11 , wherein the nucleic acid-guided has less than 40% protein identity to SEQ ID No. 12 and SEQ ID No. 108.

14 . The system of claim 11 , wherein the nucleic acid-guided nuclease is codon optimized for the cell to be edited.

15 . The system of claim 14 , wherein the nucleic acid-guided nuclease is codon optimized for E. coli.

16 . The system of claim 14 , wherein the nucleic acid-guided nuclease is codon optimized for S. cerevisiae.

17 . The system of claim 14 , wherein the nucleic acid-guided nuclease is codon optimized for mammalian cells.

18 . The system of claim 11 , wherein the engineered guide nucleic acid and the editing sequence are provided as a single nucleic acid.

19 . The system of claim 11 , wherein the non-naturally occurring nucleic acid-guided nuclease is encoded by a nucleic acid having at least 95% identity to SEQ ID No. 22, SEQ ID No. 42, SEQ ID No. 128 or SEQ ID No. 148.

20 . The system of claim 11 , wherein the non-naturally occurring nucleic acid-guided nuclease is encoded by a nucleic acid having at least 95% identity to SEQ ID No. 22, SEQ ID No. 42, SEQ ID No. 128 or SEQ ID No. 148

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2020
From: GARST, ANDREW; GILL, RYAN T.; WARNECKE LIPSCOMB, TANYA ELIZABETH
To: MUSE BIOTECHNOLOGY, INC.
Reel/Frame 052177/0632 →
CHANGE OF NAME Recorded Mar 16, 2020
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 052177/0737 →